Anticancer Effect of Rosiglitazone, a PPAR‑γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis

• Yanqiao Wu,
• Nagaraja Sreeharsha,
• Sanjay Sharma,
• Anurag Mishra,
• Avinash Kumar Singh,
• Shiva Kumar Gubbiyappa

Affiliations

Yanqiao Wu

Intensive Care Unit, People’s Hospital of Ningjin County, Ningjin County, Shandong province, China

Nagaraja Sreeharsha

Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia

Sanjay Sharma

NMIMS, School of Pharmacy and Technology Management, Shirpur, Maharashtra, India

Anurag Mishra

School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India

Avinash Kumar Singh

Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India

Shiva Kumar Gubbiyappa

School of Pharmacy, GITAM University, Hyderabad, India